-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Urgent need to understand the new crown pneumonia personal rehabilitation if protected, it is no longer infected with SARS-CoV-2.
Coronavirus disease
Since June 2020, there have been reports of re-infections internationally, although this situation is still uncommon.
Participants were recruited from public hospitals in all regions of England.
From June 18, 2020 to December 31, 2020, 30,625 participants participated in this study.
From March 2020 to January 2021, based on the baseline cohort allocation, the frequency of SIREN participants who tested positive for the first PCR each week
From March 2020 to January 2021, based on the baseline cohort allocation, the frequency of SIREN participants who tested positive for the first PCR each weekAfter a 7-month follow-up, this large observational study showed that most people who were previously infected with SARS-CoV-2 can be protected from SARS-CoV-2 for an average of 7 months .
Most people who were previously infected with SARS-CoV-2 can be protected from SARS-CoV-2 for an average of 7 months, and most people who have previously been infected with SARS-CoV-2 can be protected from SARS-CoV for an average of 7 months -2 The first infection with SARS-CoV-2 can provide a high degree of immunity for repeated infections in the short and medium term.
A previous history of SARS-CoV-2 infection was associated with an 84% reduction in the risk of infection.
Hall Victoria Jane,Foulkes Sarah,Charlett Andre et al.
Hall Victoria Jane,Foulkes Sarah,Charlett Andre et al.
Leave a message here
